Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations]
Introduction Sexual dysfunctions are common yet underreported side effects of antipsychotics for schizophrenia, affecting 30-80% of treated individuals. These side effects can severely impact social interactions and treatment adherence for individuals with schizophrenia, but comprehensive comparativ...
Saved in:
| Main Authors: | Wulf Peter Hansen, Spyridon Siafis, Orestis Efthimiou, Shimeng Dong, Johannes Schneider-Thoma, David D. Kim, Stefan Leucht, Karl Heinz Möhrmann, Elfriede Scheuring |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2025-06-01
|
| Series: | F1000Research |
| Subjects: | |
| Online Access: | https://f1000research.com/articles/13-973/v3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 2; peer review: 2 approved, 1 approved with reservations]
by: Wulf Peter Hansen, et al.
Published: (2025-02-01) -
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 1 approved, 2 approved with reservations]
by: Spyridon Siafis, et al.
Published: (2025-01-01) -
Haloperidol versus second-generation antipsychotics on the cognitive performance of individuals with schizophrenia and related disorders: pairwise meta-analysis of randomized controlled trials
by: Daniel Prates Baldez, et al.
Published: (2025-05-01) -
Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01) -
Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01)